New Twice-Yearly Inclisiran Therapy Shows Major Reduction in LDL Cholesterol - Medscape

New Twice-Yearly Inclisiran Therapy Shows Major Reduction in LDL Cholesterol Medscape New cholesterol treatment could be 'game changer' for Spokane, says MultiCare cardiologist The Spokesman-Review Newly approved pill cuts LDL cholesterol levels by more than half Harvard Health FDA Approves New Pill That Lowers Cholesterol Levels By Nearly 60% Healthline We’re beating heart disease vox.